Tag:
Abiomed
Latest Headlines
Latest Headlines
Abiomed, aided by its Impella heart pumps, ends FY 2012 in the black
The Danvers, MA device company ended its 2012 fiscal year in the black, with record revenue in hand, thanks in large part to its Impella pumps, which are designed to aid an ailing heart rather than replace it.
Abiomed snags CE mark for Impella cVAD heart pump
Abiomed ($ABMD) is gearing up for a full European commercial launch of its Impella cVAD heart pump by this summer, now that it has obtained a CE mark for the device.
Abiomed ($ABMD) ends PROTECT II study
Abiomed ($ABMD) has ended its PROTECT II study of its Impella cardiac assist device based on a recommendation of a data safety monitoring board. The company's shares dipped 14 percent at $10.50 after
Abiomed shells out $100,000 to lobby feds
It's always good to have friends in high places in Washington. And in the nation's capitol, you can always buy new ones . In another
